Compound Evidence File
#EC-2026-0754
Phenylacetic acid CAS 103-82-2
Filed under Raw Materials. The bureau holds 142 laboratory returns for this compound from 43 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
43 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 8 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 10.0 | 9.9 | 10.0 | 2 May 2026 | 3 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 10.0 | 9.9 | 10.0 | 8 Feb 2026 | 20 Jun 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 9.9 | 10.0 | 9 Mar 2026 | 10 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 10.0 | 9.9 | 10.0 | 5 Jan 2026 | 23 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 9.9 | 10.0 | 7 May 2026 | 11 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 9.9 | 10.0 | 16 May 2026 | 25 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 3 | 10.0 | 9.9 | 10.0 | 14 Feb 2026 | 12 Aug 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 10.0 | 10.0 | 10.0 | 9 May 2026 | 21 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 10.0 | 10.0 | 10.0 | 6 Feb 2026 | 6 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 10.0 | 10.0 | 10.0 | 17 Mar 2026 | 25 May 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 10.0 | 10.0 | 10.0 | 19 Mar 2026 | 22 Jun 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 6 | 9.9 | 9.9 | 10.0 | 21 May 2026 | 21 May 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 9.9 | 9.9 | 10.0 | 23 Jan 2026 | 12 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 4 | 9.9 | 9.9 | 10.0 | 13 Mar 2026 | 9 Jun 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 9.9 | 9.9 | 10.0 | 21 Feb 2026 | 14 Aug 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 9.9 | 9.9 | 10.0 | 2 Apr 2026 | 12 Jun 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 9.9 | 9.9 | 10.0 | 4 Feb 2026 | 19 Aug 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 2 | 9.9 | 9.9 | 10.0 | 5 Jun 2026 | 6 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 9.9 | 9.9 | 9.9 | 9 Feb 2026 | 8 Jul 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 9.9 | 9.9 | 10.0 | 1 Jul 2026 | 16 Jul 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 9.9 | 9.9 | 10.0 | 13 May 2026 | 3 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 9.9 | 9.9 | 10.0 | 27 Jun 2026 | 18 Jul 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 3 | 9.0 | 8.6 | 9.7 | 21 May 2026 | 21 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 8 | 8.7 | 7.7 | 9.8 | 21 May 2026 | 21 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 8 | 8.6 | 7.6 | 9.6 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 8 | 8.5 | 7.3 | 10.0 | 25 May 2026 | 25 May 2026 |
| Shanghai Leader Peptide BiotechnologyCASE #VI-2026-0558 | X | 1 | 8.5 | 8.5 | 8.5 | 6 May 2025 | 6 May 2025 |
| Yiwu Aozuo Trading CoCASE #VI-2026-0798 | X | 8 | 8.2 | 6.9 | 10.0 | 25 Apr 2025 | 21 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 6 | 7.9 | 7.3 | 8.7 | 25 May 2026 | 25 May 2026 |
| Golden EagleCASE #VI-2026-0680 | X | 1 | 7.9 | 7.9 | 7.9 | 2 Jul 2025 | 2 Jul 2025 |
| Simple PeptideCASE #VI-2026-0782 | X | 1 | 7.3 | 7.3 | 7.3 | 13 Feb 2025 | 13 Feb 2025 |
| Amino AsylumCASE #VI-2026-0828 | X | 1 | 7.1 | 7.1 | 7.1 | 2 Apr 2025 | 2 Apr 2025 |
| Accelerate LabsCASE #VI-2026-0686 | X | 1 | 6.9 | 6.9 | 6.9 | 8 Jul 2025 | 8 Jul 2025 |
| LiliPeptideCASE #VI-2026-0695 | X | 13 | 6.7 | 4.6 | 8.9 | 25 Apr 2025 | 17 May 2026 |
| Peptide WorldwideCASE #VI-2026-0217 | X | 1 | 5.9 | 5.9 | 5.9 | 14 Jan 2025 | 14 Jan 2025 |
| YB PeptideCASE #VI-2026-0813 | X | 1 | 5.9 | 5.9 | 5.9 | 16 Mar 2025 | 16 Mar 2025 |
| Allen Biotechnology Co ABCCASE #VI-2026-0709 | X | 2 | 5.5 | 5.4 | 5.6 | 3 Jul 2025 | 21 May 2026 |
| Shanghai BaojuCASE #VI-2026-0233 | X | 2 | 5.3 | 4.5 | 6.2 | 17 Dec 2024 | 20 May 2026 |
| NuLife PeptidesCASE #VI-2026-0980 | X | 1 | 3.1 | 3.1 | 3.1 | 27 Feb 2025 | 27 Feb 2025 |
| Hebei Chengtong TechnologyCASE #VI-2026-0520 | X | 1 | 2.0 | 2.0 | 2.0 | 24 Apr 2025 | 24 Apr 2025 |
| Lejian Biotech PeptideCASE #VI-2026-0746 | X | 1 | 1.9 | 1.9 | 1.9 | 14 Jan 2025 | 14 Jan 2025 |
| Weifang Xingbei International TradeCASE #VI-2026-0766 | X | 1 | 0.0 | 0.0 | 0.0 | 17 Dec 2024 | 17 Dec 2024 |
Open any subject to view the batch-level evidence for Phenylacetic acid CAS 103-82-2 alone.